FoleyB, LeitnerT, ApetreiC, et al.: HIV Sequence Compendium. 2013. Los Alamos National Laboratory, Theoretical Biology and Biophysics, Los Alamos, New Mexico. LA-UR-13-26007.
2.
LeitnerT, KorberB, DanielsM, CalefC, and FoleyB: HIV-1 subtype and circulating recombinant form (CRF) reference sequences, 2005. The LANL HIV Sequence Database. http://hiv.lanl.gov/.
3.
LiL, LuX, LiH, et al.: High genetic diversity of HIV-1 was found in men who have sex with men in Shijiazhuang, China. Infect Genet Evol, 2011; 11:1487–1492.
4.
DengX, LiuH, ShaoY, RaynerS, and YangR: The epidemic origin and molecular properties of B′: A founder strain of the HIV-1 transmission in Asia. AIDS, 2008; 22(14):1851–1858.
5.
LiY, UenishiR, HaseS, et al.: Explosive HIV-1 subtype B′ epidemics in Asia driven by geographic and risk group founder events. Virology, 2010; 402(2):223–227.
6.
LiY, TakebeY, YangJ, ZhangW, and YangR: High prevalence of HIV type 1 subtype B′ among heterosexuals in Western Hubei, Central China: Bridging the epidemic into the general population. AIDS Res Hum Retroviruses, 2011; 27(9):1025–1028.
7.
DangS, WangY, BudeusB, VerheyenJ, YangR, and HoffmannD: Differential selection in HIV-1 gp120 between subtype B and East Asian variant B′. Virol Sin, 2014; 29(1):40–47.
8.
MascolaJR, D'SouzaP, GilbertP, et al.: Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines. J Virol, 2005; 79(16):10103–10107.
9.
decampA, HraberP, BailerRT, et al.: Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol, 2014; 88(5):2489–2507.
